Recce Pharmaceuticals Announces Lead Synthetic Anti-infective RECCE® 327 Progresses to Stage 2 of SARS-CoV-2 Antiviral Screening Program at CSIRO

NEXT STORY
Apollomics Inc. Announces Official Opening of Shanghai Branch
PREV STORY
Clinical Nutrition: Global Markets to 2025
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeyondSpring to Present Positive Data From Prospective Phase 2 Trial Comparing Plinabulin to Neulasta for the Prevention of Chemotherapy-Induced Neutropenia at 2018 ASCO Annual Meeting

Data Demonstrated Comparable Results in Duration of Severe Neutropenia for Plinabulin and Neulasta Treatment ...

author_avatar
NASDAQ Market News

Surgical Care Affiliates (SCA), OptumCare to Combine

Creates comprehensive ambulatory care services platform, including primary care, urgent care and surgical care ...

author_avatar
NASDAQ Market News

ADMA Biologics Provides Regulatory Update for BIVIGAM®

FDA PDUFA Action AnticipatedRAMSEY, N.J. and BOCA RATON, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) ...

author_avatar
NASDAQ Market News